» Articles » PMID: 12646560

Activation of the ERK1/2 Signaling Pathway Promotes Phosphorylation and Proteasome-dependent Degradation of the BH3-only Protein, Bim

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Mar 21
PMID 12646560
Citations 273
Authors
Affiliations
Soon will be listed here.
Abstract

Both the ERK and phosphatidylinositol 3'-kinase (PI3K) signaling pathways can protect cells from apoptosis following withdrawal of survival factors. We have previously shown that the ERK1/2 pathway acts independently of PI3K to block expression of the BH3-only protein, BimEL, and prevent serum withdrawal-induced cell death, although the precise mechanism by which ERK reduced BimEL levels was unclear. By comparing Bim mRNA and Bim protein, expression we now show that the rapid expression of BimEL following serum withdrawal cannot be accounted for simply by increases in mRNA following inhibition of PI3K. In cells maintained in serum BimEL is a phosphoprotein. We show that activation of the ERK1/2 pathway is both necessary and sufficient to promote BimEL phosphorylation and that this leads to a substantial increase in turnover of the BimEL protein. ERK1/2-dependent degradation of BimEL proceeds via the proteasome pathway because it is blocked by proteasome inhibitors and is defective at the restrictive temperature in cells with a temperature-sensitive mutation in the E1 component of the ubiquitin-conjugating system. Finally, co-transfection of BimEL and FLAG-ubiquitin causes the accumulation of polyubiquitinated forms of Bim, and this requires the ERK1/2 pathway. Our findings provide new insights into the regulation of Bim and the role of the ERK pathway in cell survival.

Citing Articles

Signalling pathways involved in urotensin II induced ventricular myocyte hypertrophy.

Al Ali H, Rodrigo G, Lambert D PLoS One. 2025; 20(1):e0313119.

PMID: 39820183 PMC: 11737703. DOI: 10.1371/journal.pone.0313119.


TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis.

Loos B, Salas-Bastos A, Nordin A, Debbache J, Stierli S, Cheng P Cell Death Dis. 2024; 15(12):925.

PMID: 39709491 PMC: 11663225. DOI: 10.1038/s41419-024-07305-1.


ONC212, alone or in synergistic conjunction with Navitoclax (ABT-263), promotes cancer cell apoptosis via unconventional mitochondrial-independent caspase-3 activation.

Basu V, Shabnam , Murghai Y, Ali M, Sahu S, Verma B Cell Commun Signal. 2024; 22(1):441.

PMID: 39272099 PMC: 11395312. DOI: 10.1186/s12964-024-01817-1.


Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.

Becker J, Metropulos A, Spaulding C, Marinelarena A, Shields M, Principe D Cancer Res. 2024; 84(21):3629-3639.

PMID: 39137400 PMC: 11532783. DOI: 10.1158/0008-5472.CAN-23-3574.


Notopterygium Incisum Extract Promotes Apoptosis by Preventing the Degradation of BIM in Colorectal Cancer.

Chen J, Wei C, Lin Q, Wang Z, Zhang F, Shi M Curr Med Sci. 2024; 44(4):833-840.

PMID: 38967889 DOI: 10.1007/s11596-024-2883-1.